
U.S. Rep. Ruben Gallego, D-Ariz., speaks at the Capitol, Thursday, April 6, 2023, in Phoenix. Gallego was discussing newly announced water conservation funding for Gila River Indian Community and water users across the Colorado River Basin aimed to protect the stability and sustainability of the Colorado River System. (AP Photo/Matt York)
Representatives Ruben Gallego (D-Arizona) and Elissa Slotkin (D-Michigan) teamed up this week to introduce the Lower Drug Costs for Families Act, a bill which would hold Big Pharma accountable for price gouging.
The bill would require drug companies to pay a penalty if they raise prices faster than inflation. Thanks to last year’s Inflation Reduction Act, the federal government can limit drug price increases faster than the rate of inflation for drugs purchased and used by people on Medicare.
But Gallego and Slotkin’s bill would expand this to include drugs purchased and used by people with private health insurance. Under the proposal, all penalties paid by companies would go towards preserving the Medicare Trust fund. One estimate suggests it could save the federal government $34 billion over the next 10 years.
“For years, Arizonans have been struggling to afford prescription drug prices that have skyrocketed far above inflation,” Gallego, who is running for Senate in 2024, said in a statement. “With the historic Inflation Reduction Act, we were able to put an end to drug price gouging for seniors. Now, it’s time to expand those protections to all Arizonans. That’s exactly what my bill does.”
Outrage over prescription drug price-gouging is nothing new.
As philanthropic organization Arnold Ventures notes, pharmaceutical companies have “gamed the U.S. patent system and engaged in anti-competitive behaviors to drive up prices” for decades.
A recent report from the Senate Health, Education, Labor, and Pensions Committee also outlined how “pharmaceutical corporations use taxpayer-funded research to develop products to sell back to those same taxpayers for exorbitant profits,” and how “U.S. taxpayers virtually always pay more than people in other countries for treatments that [government] scientists helped invent.”
For example, Prezista, an HIV medication manufactured by Johnson & Johnson, has a list price of $25,000 in the United States. In Germany, the list price for that same medication is $4,000. Prezcobix, another HIV medication manufactured by Johnson & Johnson, has a list price of $29,000 in the U.S. In Japan, the list price is $5,000.
This type of price gouging isn’t exclusive to HIV medication either. For years, the three major insulin makers steadily raised the prices of the life-saving medication—so much so that over a 20-year period, the cost of insulin increased by an astonishing 600%. These price hikes came as the cost of producing insulin remained stable, between $3.69 and $6.16 a vial, according to one 2018 study.
The high costs of drugs have made it difficult for many Americans to afford the medication they need to live—so difficult in fact that 17% of insulin users reported either delaying buying insulin, taking less than needed, or skipping a dose due to cost reasons. This can lead to diabetic ketoacidosis, a life-threatening complication that occurs when the body doesn’t have enough insulin.
While Americans are struggling to afford the medication they need to live, these pharmaceutical companies are raking in money. Pfizer reported revenues of over $100 billion in 2022 alone and Merck’s annual revenue last year was nearly $60 billion.
The Lower Drug Costs for Families Act has been endorsed by Patients for Affordable Drugs Now, the American Federation of State, Communications Workers of America (CWA), the American Federation of Teachers, and more. Sen. Catherine Cortez Masto (D-Nevada) introduced the Senate version of Gallego and Slotkin’s bill earlier this year.

These 5 Arizona hospitals are at risk of closing now that Trump’s ‘One Big Beautiful Bill Act’ is law
People in rural areas of Arizona will likely face greater health and injury risks, now that President Donald Trump’s “One Big Beautiful Bill Act”...

2 million Arizonans could be impacted by a US Supreme Court ruling for South Carolina
Arizonans who receive health care through Medicaid could soon lose access to services at Planned Parenthood and other clinics that offer abortion...

States can cut off Medicaid funding to Planned Parenthood, the Supreme Court rules
The ruling authored by Justice Neil Gorsuch and joined by the rest of the court's conservatives could have broader implications for Medicaid...

Arizona officials confirm measles outbreak in Navajo County
Health officials in Arizona say there are four linked measles cases in Navajo County, marking the state's first outbreak this year. The U.S. logged...